 LEEDS, England--BUSINESS WIRE--4D pharma plc AIM: DDD, a pharmaceutical company leading the development of Live Biotherapeutic products LBPs - a novel class of drug derived from the microbiome, today announced that 4D management will present at three upcoming investor conferences: Chardans Virtual 3rd Annual Microbiome Medicines Summit: Monday March 8, 2021 at 11:45 am ET 16:45 GMT. H.C. Wainwright Global Life Sciences Conference: Available on-demand starting Tuesday, March 9, 2021 at 